Shape and dimensions Sample Clauses

Shape and dimensions. 3.1.1. The shape and dimensions of samples are given in Figure 6. The thickness of the sample corresponds to the thickness of the product to be tested. It shall not be more than 13 mm. When taking the sample permits, the sample shall have a constant section over its entire length. Figure 6 Sample (Dimensions in millimetres) 3.1.2. If the shape and dimensions of a product do not permit taking a sample of the given size, the following minimum dimensions shall be maintained: (a) For samples having a width of 3 to 60 mm, the length shall be 356 mm. In this case the material is tested in the product's width; (b) For samples having a width of 60 to 100 mm, the length shall be at least 138 mm. In this case the potential burning distance corresponds to the length of the sample, the measurement starting at the first measuring point.
Shape and dimensions. As per the VT-200-F drawing shown on page 5 .
Shape and dimensions. Colouring of the plastic product .............................................................................................. Nature of the surface coating ................................................................................................... Secondary characteristics: Conductors incorporated (yes/no) ........................................................................................... Obscuration incorporated (yes/no) .......................................................................................... Remarks Documents attached: list of windscreens (see Appendix 13) (Principal and secondary characteristics as defined in Annex 18 to Regulation No. 43) Approval No. …………………………… Extension No. …………………………. Principal characteristics: Number of layers of plastic ..................................................................................................... Number of layers of interlayer ................................................................................................ Nominal thickness ................................................................................................................... Nominal thickness of interlayer (s............................................................................................ Nature and type of interlayer (s) .............................................................................................. Special treatment of plastic ..................................................................................................... Colouring of plastic product .................................................................................................... Chemical designation of single sheet material ........................................................................ Classification of the material ................................................................................................... Process of manufacture ...........................................................................................................
Shape and dimensions. As per the SSP-T7-F drawing shown on page 5 .
Shape and dimensions. As per the SP-T2A-F drawing shown on page 5 .
Shape and dimensions. Nature of the surface coating ...................................................................................................
Shape and dimensions. The shape and dimensions of samples are given in figure 20. The thickness of the sample corresponds to the thickness of the product to be tested. It shall not be more than 13 mm. When sample-taking so permits, the sample shall have a constant section over its entire length. When the shape and dimensions of a product do not permit taking a sample of the given size, the following minlmimi dimensions shall be observed : (a) for samples having a width of 3 to 60 шш, the length shall be 356 mm. In this case the material is tested over the product's width; (b) for samples having a width of 60 to 100 шш, the length shall be at least 138 ШШ. In this case the potential burning distance corresponds to the length of the sample, the measurement starting at the first measuring (c) samples less than 60 mm wide and less than 356 пш. long, 'and samples 60 to

Related to Shape and dimensions

  • Permitted Use and Disclosures Each Party hereto may use or disclose Confidential Information disclosed to it by the other Party to the extent such information is included in the Pharmacopeia Technology, Schering Technology or Collaboration Technology, as the case may be, and to the extent (i) such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder in filing or prosecuting patent applications, prosecuting or defending litigation, (ii) such disclosure is reasonably required to be made to any institutional review board of any entity conducting clinical trials with Agreement Compound(s) and/or Agreement Product(s), or to any governmental or other regulatory agency, in order to gain approval to conduct clinical trials or to market Agreement Compound(s) and/or Agreement Products, (iii) such disclosure is required by law, regulation, rule, act or order of any governmental authority, court, or agency, or is made in connection with submitting required information to tax or other governmental authorities, or (iv) such disclosure or use is reasonably required in conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted to it by the other Party pursuant to the terms of this Agreement; in each case, provided that if a Party is required to make any such disclosure of another Party’s Confidential Information, other than pursuant to a confidentiality agreement, it will give reasonable advance notice to the other Party of such disclosure and, save to the extent inappropriate in the case of patent applications, will use its reasonable diligent efforts to secure confidential treatment of such Confidential Information in consultation with the other Party prior to its disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

  • Permitted Uses and Disclosures of PHI and the third party notifies the Business Associate of any instances of which it is aware in which the confidentiality of the information has been breached.

  • Permitted Uses and Disclosures i. Business Associate shall use and disclose PHI only to accomplish Business Associate’s obligations under the Contract. i. To the extent Business Associate carries out one or more of Covered Entity’s obligations under Subpart E of 45 C.F.R. Part 164, Business Associate shall comply with any and all requirements of Subpart E that apply to Covered Entity in the performance of such obligation. ii. Business Associate may disclose PHI to carry out the legal responsibilities of Business Associate, provided, that the disclosure is Required by Law or Business Associate obtains reasonable assurances from the person to whom the information is disclosed that: A. the information will remain confidential and will be used or disclosed only as Required by Law or for the purpose for which Business Associate originally disclosed the information to that person, and; B. the person notifies Business Associate of any Breach involving PHI of which it is aware. iii. Business Associate may provide Data Aggregation services relating to the Health Care Operations of Covered Entity. Business Associate may de-identify any or all PHI created or received by Business Associate under this Agreement, provided the de-identification conforms to the requirements of the HIPAA Rules.

  • PROPRIETARY/RESTRICTIVE SPECIFICATIONS If a prospective bidder considers the specification contained herein to be proprietary or restrictive in nature, thus potentially resulting in reduced competition, they are urged to contact the Procurement Division prior to bid opening. Specifications which are unrelated to performance will be considered for deletion via addendum to this Invitation for Bids.

  • PERMITTED USES AND DISCLOSURES BY CONTRACTOR Except as otherwise limited in this Schedule, Contractor may use or disclose Protected Health Information to perform functions, activities, or services for, or on behalf of, County as specified in the Agreement; provided that such use or disclosure would not violate the Privacy Rule if done by County.